Description
High-Stability Polypeptide for Laboratory Evaluation
Technical Overview
Retatrutide is a synthetic peptide engineered to interact with multiple metabolic receptor systems including GLP-1, GIP, and glucagon receptors. In laboratory studies, this compound is utilized for examining receptor binding dynamics and endocrine pathway signaling. Retatrutide is synthesized via solid-phase peptide synthesis and undergoes multi-stage purification to ensure high-purity analytical standards suitable for controlled research environments.
Specifications
| CAS Number | 2381089-83-2 |
|---|---|
| Amino Acid Count | 39 |
| Amino Acid Sequence | 39-residue GIP/GLP-1/glucagon triple agonist with Aib residues, α-Me-Leu, and a Lys-conjugated (AEEA)-γGlu-C20 diacid; C-terminal serinamide (per COA) |
| Purity | ≥99% by HPLC · COA available |
| Physical Form | Lyophilized powder |
| Solubility | Soluble in bacteriostatic water; consult the product COA for specific solvent recommendations. |
| Storage Conditions | Store lyophilized at -20°C; protect from light and moisture. Reconstitute with bacteriostatic water; refrigerate reconstituted solution at 2-8°C. |
Notice
Maverick Labs provides this compound as a reference material for scientific inquiry. All applications must be conducted by qualified professionals in controlled laboratory environments.
This product is for Research Use Only. Not for use in diagnostic, therapeutic, or human or animal in-vivo procedures. This product is sold exclusively for in-vitro laboratory research use. It is not a drug, dietary supplement, food, or cosmetic and has not been approved by the U.S. Food and Drug Administration for any use. Not for human or animal consumption.
Reviews
There are no reviews yet.